4.6 Article

Intranasal neuropeptide Y1 receptor antagonism improves motor deficits in symptomatic SOD1 ALS mice

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Clinical Neurology

Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis

Hannah C. Timmins et al.

Summary: Identification of upper motor neuron involvement is crucial for diagnosing ALS, but it is often difficult to detect in the early stages of the disease. Recent research has uncovered new pathophysiological processes and diagnostic tools, such as TMS, that may help in the detection and treatment of ALS. Advances in genetics have also changed the understanding of ALS and its relationship to other neurodegenerative disorders.

CURRENT OPINION IN NEUROLOGY (2023)

Article Cell Biology

Enhanced motor cortex output and disinhibition in asymptomatic female mice with C9orf72 genetic expansion

Sona Amalyan et al.

Summary: This study reveals that asymptomatic mice carrying the C9orf72 gene mutation exhibit abnormal motor cortex output. The reduction in the number of pyramidal neurons in the M1 layer 5 and the decreased inhibitory drive in surviving neurons result in higher M1 output, particularly during high-speed animal locomotion. Furthermore, the study shows that the speed-dependent M1 output can predict the likelihood of C9orf72 genetic expansion.

CELL REPORTS (2022)

Review Biochemistry & Molecular Biology

Pathogenic or protective? Neuropeptide Y in amyotrophic lateral sclerosis

Courtney M. Clark et al.

Summary: NPY has gained interest as a potential neuroprotective agent for neurodegenerative diseases, with evidence suggesting a possible role in ALS pathogenesis. While increased NPY levels correlate with disease progression in ALS, the functional consequences are not fully understood.

JOURNAL OF NEUROCHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Mislocalisation of TDP-43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex

Marcus S. Dyer et al.

Summary: ALS is a chronic neurodegenerative disease characterized by mislocalisation of the TDP-43 protein from the nucleus to the cytoplasm. Research in mouse models indicates that mislocalised TDP-43 causes intrinsic hyperexcitability and synaptic dysfunction in motor cortex neurons.

JOURNAL OF NEUROCHEMISTRY (2021)

Article Biochemical Research Methods

A scalable, fully automated approach for regional quantification of immunohistochemical staining of astrocytes in the rat brain

Caitlin A. Finney et al.

Summary: The study presents an optimized QuPath protocol that is scalable, fully automated, and compatible with whole slide scanning technology. Among various methods for quantifying astrocytic responses in the brain using GFAP and DAB immunohistochemistry, positive proportion appears to be the most effective.

JOURNAL OF NEUROSCIENCE METHODS (2021)

Review Neurosciences

NPY and Gene Therapy for Epilepsy: How, When, ... and Y ...

Stefano Cattaneo et al.

Summary: Neuropeptide Y is a pleiotropic molecule that influences cell proliferation, cardiovascular and metabolic function, pain, and neuronal excitability, with potential anti-epileptic effects. Overexpression of NPY in the brain with viral vectors can suppress seizures in animal models of epilepsy, suggesting a novel approach for epilepsy treatment. However, further research is needed to fully understand the therapeutic potential of NPY-based gene therapy for epilepsy.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)

Article Multidisciplinary Sciences

Neuropeptide Y (NPY) intranasal delivery alleviates Machado-Joseph disease

Joana Duarte-Neves et al.

Summary: Research suggests that intranasal administration of neuropeptide Y (NPY) can alleviate motor and balance impairments as well as cerebellar neuropathology in MJD mouse models, without affecting other physiological parameters.

SCIENTIFIC REPORTS (2021)

Review Clinical Neurology

Brain Stimulation as a Therapeutic Tool in Amyotrophic Lateral Sclerosis: Current Status and Interaction With Mechanisms of Altered Cortical Excitability

Federico Ranieri et al.

Summary: Neuromodulation techniques have been tested as a non-pharmacological therapeutic approach to slow disease progression in ALS, targeting excitatory and synaptic dysfunction. Non-invasive brain stimulation methods can suppress or enhance motor neuron excitability, potentially mediated by long-term potentiation (LTP)/long-term depression (LTD) mechanisms.

FRONTIERS IN NEUROLOGY (2021)

Article Cell Biology

Human amyotrophic lateral sclerosis excitability phenotype screen: Target discovery and validation

Xuan Huang et al.

Summary: Screening using patient-derived motor neurons has identified multiple effective targets for managing hyperexcitability in ALS, demonstrating the potential of human disease cell-based phenotypic screens in identifying clinically relevant targets for neurological disorders.

CELL REPORTS (2021)

Article Neurosciences

Differential NPY-Y1 Receptor Density in the Motor Cortex of ALS Patients and Familial Model of ALS

Courtney M. Clark et al.

Summary: This study investigated the density of NPY-Y1 receptors on upper motor neurons in ALS, revealing a potential novel pathway for modulating upper motor neuron activity.

BRAIN SCIENCES (2021)

Review Neurosciences

Cortical Circuit Dysfunction as a Potential Driver of Amyotrophic Lateral Sclerosis

Aurore Brunet et al.

FRONTIERS IN NEUROSCIENCE (2020)

Article Clinical Neurology

Cortical hyperexcitability evolves with disease progression in ALS

Parvathi Menon et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)

Review Neurosciences

Exciting Complexity: The Role of Motor Circuit Elements in ALS Pathophysiology

Zeynep I. Gunes et al.

FRONTIERS IN NEUROSCIENCE (2020)

Editorial Material Neurosciences

The ARRIVE guidelines 2.0: updated guidelines for reporting animal research

Nathalie Percie du Sert et al.

JOURNAL OF PHYSIOLOGY-LONDON (2020)

Article Clinical Neurology

A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder

Aleksander A. Mathe et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)

Article Clinical Neurology

Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia

Rebekah M. Ahmed et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)

Review Biochemistry & Molecular Biology

Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques

Mehdi A. J. van den Bos et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Clinical Neurology

A Randomized Dose-Ranging Study of Neuropeptide Y in Patients with Posttraumatic Stress Disorder

Sehrish Sayed et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)

Article Clinical Neurology

Epothilone D accelerates disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis

J. A. Clark et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)

Review Cell Biology

A Promising Therapeutic Target for Metabolic Diseases: Neuropeptide Y Receptors in Humans

Min Yi et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)

Review Clinical Neurology

Cortical influences drive amyotrophic lateral sclerosis

Andrew Eisen et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)

Review Clinical Neurology

Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis

Yu-ichi Noto et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)

Review Neurosciences

Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases

Joana Duarte-Neves et al.

NEUROBIOLOGY OF DISEASE (2016)

Article Clinical Neurology

Motor cortical function determines prognosis in sporadic ALS

Kazumoto Shibuya et al.

NEUROLOGY (2016)

Review Clinical Neurology

Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis

Yu-ichi Noto et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)

Article Clinical Neurology

Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS

Parvathi Menon et al.

CLINICAL NEUROPHYSIOLOGY (2015)

Article Biochemistry & Molecular Biology

Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado–Joseph disease

Joana Duarte-Neves et al.

HUMAN MOLECULAR GENETICS (2015)

Review Neurosciences

Neuropeptide Y: An Anti-Aging Player?

Mariana Botelho et al.

TRENDS IN NEUROSCIENCES (2015)

Article Clinical Neurology

Somatostatin and Neuropeptide Y Neurons Undergo Different Plasticity in Parahippocampal Regions in Kainic Acid-Induced Epilepsy

Meinrad Drexel et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)

Article Neurosciences

Induced down-regulation of neuropeptide Y-Y1 receptors delays initiation of kindling

R Benmaamar et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2003)

Article Multidisciplinary Sciences

Differential modulation of synaptic transmission by neuropeptide Y in rat neocortical neurons

A Bacci et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)